{"id":"W2100797437","doi":"10.1056/nejmoa0806104","title":"Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection","year":2009,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1087,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Valeant Pharmaceuticals International; Vertex Pharmaceuticals; Duke Clinical Research Institute; Gilead Sciences","keywords":"Telaprevir; Ribavirin; Medicine; Virology; Hepatitis C virus; Genotype; Protease inhibitor (pharmacology); Chronic hepatitis; Hepacivirus; Virus; Boceprevir; Pegylated interferon; Immunology; Viral load; Biology; Gene","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005388426,0.0003459898,0.0004873591,0.0002436407,0.0003409032,0.0001366491,0.0002170135,0.0002832221,0.003817783],"category_scores_gemma":[0.0006307825,0.00008324195,0.0003013228,0.0001858233,0.0001711772,0.0001501536,0.0002076157,0.0003926398,0.0007069154],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001925008,"about_ca_system_score_gemma":0.000378905,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003600216,"about_ca_topic_score_gemma":0.000794535,"domain_scores_codex":[0.999731,0.0001040931,0.00002992863,0.00003913897,0.00004091032,0.00005498171],"domain_scores_gemma":[0.9997621,0.0000570934,0.00005902174,0.0000132336,0.00001213587,0.00009643929],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.09954456,0.00748443,0.06469233,0.001312052,0.0005343179,0.002112233,0.0002633105,0.001408766,0.02825957,0.000336124,0.005985869,0.7880664],"study_design_scores_gemma":[0.1571385,0.2934881,0.4470761,0.0007189825,0.001147079,0.02157931,0.0002273728,0.00392429,0.01711636,0.001109456,0.05638251,0.00009186562],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98413,0.008409427,0.0007814032,0.0006233446,0.0001334533,0.0008270983,0.0001757858,0.00006265958,0.00485681],"genre_scores_gemma":[0.9932938,0.002221331,0.001182484,0.0006472666,0.0002620914,0.0004530425,0.0002722763,0.000004709719,0.00166305],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003817783,"threshold_uncertainty_score":0.01277179,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02947302356834185,"score_gpt":0.3358792846128763,"score_spread":0.3064062610445344,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}